Inmune Bio, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Agency Agreements (3 contracts)
- Development Agreements (1)
- Sales Agreements (5)
- Voting Agreements (1)
- At-the-Market Sales Agreement, dated August 9, 2024, by and among INmune Bio Inc., RBC Capital Markets, LLC and BTIG, LLC (Filed With SEC on August 9, 2024)
- Form of Placement Agency Agreement (Filed With SEC on April 26, 2024)
- Form of Placement Agency Agreement (Filed With SEC on April 22, 2024)
- Amendment No. 1 to At-the-Market Sales Agreement, dated August 16, 2023, between INmune Bio Inc., and BTIG, LLC (Filed With SEC on August 16, 2023)
- Form of Placement Agency Agreement (Filed With SEC on July 15, 2021)
- At-The-Market Sales Agreement, dated March 10, 2021, between the Company and BTIG (Filed With SEC on March 11, 2021)
- Amendment No. 1 to At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on August 19, 2020)
- At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on April 17, 2020)
- Voting Agreement between INmune Bio Inc. and Xencor, Inc (Filed With SEC on August 30, 2018)
- Joint Development Agreement between INmune Bio, Inc. and Novamune (Filed With SEC on August 30, 2018)
